The balance between IL-1 and IL-1Ra in disease (Q28200818)

Europe PubMed Central

title

The balance between IL-1 and IL-1Ra in disease (English)

0 references

1 reference

William P Arend

1

0 references

language of work or name

English

0 references

publication date

2002

1 reference

Cytokine and Growth Factor Reviews

PubMed

published in

0 references

volume

13

0 references

issue

4-5

0 references

page(s)

323-40

0 references

cites work

Interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The two interleukin-1 receptors play different roles in IL-1 actions.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist: role in biology

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Detection of an interleukin-1 intracellular receptor antagonist mRNA variant.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Production of interleukin-1-receptor antagonist during experimental endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase proteinin vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Human intraovarian interleukin-1 (IL-1) system: highly compartmentalized and hormonally dependent regulation of the genes encoding IL-1, its receptor, and its receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Ovarian interleukin-1 receptor antagonist in rats: gene expression, cellular localization, cyclic variation, and hormonal regulation of a potential determinant of interleukin-1 action

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The natural interleukin-1 receptor antagonist in term and preterm parturition

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin 1 receptor antagonist blocks somnogenic and pyrogenic responses to an interleukin 1 fragment

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The effect of synovial tissue on the breakdown of articular cartilage in organ culture

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Isolation of an interleukin-1-like factor from human joint effusions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Release of interleukin-1 from human synovial tissue in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Macrophage- and neutrophil-dominant arthritis in human IL-1 alpha transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies. Potential contribution from synovial fluid neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Differential expression of two major cytokines produced by neutrophils, interleukin-8 and the interleukin-1 receptor antagonist, in neutrophils isolated from the synovial fluid and peripheral blood of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

An interleukin 1 inhibitor affects both cell-associated interleukin 1-induced T cell proliferation and PGE2/collagenase production by human dermal fibroblasts and synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Modulation of the effects of interleukin-1 on glycosaminoglycan synthesis by the urine-derived interleukin-1 inhibitor, but not by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Regulatory role of interleukin 10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis. More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Altered susceptibility to collagen-induced arthritis in transgenic mice with aberrant expression of interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Evaluation of an interleukin-1 receptor antagonist in the rat acetic acid-induced colitis model

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Differential expression of interleukin 1 receptor antagonist isoforms in human intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Regulatory effects of endogenous interleukin-1 receptor antagonist protein in immunoglobulin G immune complex-induced lung injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Post-insult treatment with interleukin-1 receptor antagonist decreases oxidative lung injury in rats given intratracheal interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Potential role of interleukin-1 in allergen-induced late asthmatic reactions in guinea pigs: suppressive effect of interleukin-1 receptor antagonist on late asthmatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Significance of the interleukin-1 receptor antagonist/interleukin-1 beta ratio as a prognostic factor in patients with pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Modulation of antibody-mediated glomerular injury in vivo by IL-1ra, soluble IL-1 receptor, and soluble TNF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Kidney as a major clearance organ for recombinant human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Does increased urinary interleukin-1 receptor antagonist/interleukin-1beta ratio indicate good prognosis in renal transplant recipients?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Preparation of specific antibodies against murine IL-1ra and the establishment of IL-1ra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Defective interleukin-1 receptor antagonist production is associated with resistance of acute liver graft rejection to steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Acute pancreatitis-induced enzyme release and necrosis are attenuated by IL-1 antagonism through an indirect mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

SCF, IL-1beta, IL-1ra and GM-CSF in the bone marrow and serum of normal individuals and of AML and CML patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Growth modulation of human prostatic cancer cells by interleukin-1 and interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist mRNA expression and the progression of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Cytokine RNA levels in transiliac bone biopsies from healthy early postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Biochemical and Molecular Actions of Interleukin-1 on Pancreatic β-Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

An interleukin-1 receptor antagonist protein protects insulin-producing Beta cells against suppressive effects of interleukin-1?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic beta-cell destruction in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist prevents low dose streptozotocin induced diabetes in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese diabetic (NOD) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Localization of Interleukin-1 Receptor Antagonist mRNA in Rat Brain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Role of IL-1alpha and IL-1beta in ischemic brain damage.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Endogenous interleukin-1 receptor antagonist is neuroprotective

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

HIV-1 exposed dendritic cells show increased pro-inflammatory cytokine production but reduced IL-1ra following lipopolysaccharide stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Upregulation of fibronectin synthesis by interleukin-1 beta in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Temporal and spatial distribution of interleukin-1β in balloon injured porcine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Expression of interleukin-1beta, interleukin-1 receptor, and interleukin-1 receptor antagonist mRNA in rat carotid artery after balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Viral myocarditis leading to cardiomyopathy: do cytokines contribute to pathogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The inhibitor cytokine interleukin-1 receptor antagonist synergistically augments cyclosporine immunosuppression in a rat cardiac allograft model

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Cardiac graft intercellular adhesion molecule-1 (ICAM-1) and interleukin-1 expression mediate primary isograft failure and induction of ICAM-1 in organs remote from the site of transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Intracellular precursor interleukin (IL)-1alpha, but not mature IL-1alpha, is able to regulate human endothelial cell migration in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Synthesis and secretion of interleukin-1 alpha and interleukin-1 receptor antagonist during differentiation of cultured keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Length variation within intron 2 of the human IL-1 receptor antagonist protein gene (IL1RN)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Biological role of interleukin 1 receptor antagonist isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Severity of Alopecia Areata Is Associated with a Polymorphism in the Interleukin-1 Receptor Antagonist Gene

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Genetic markers in clinically well defined patients with ulcerative colitis (UC)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and Crohn disease in multiple populations from northeast England

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Influence of interleukin-10 on the interleukin-1 receptor antagonist/interleukin-1 beta ratio in the colonic mucosa of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist gene in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Genetic polymorphisms of IL-1beta and IL-1 receptor antagonist in association with multiple sclerosis in Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjögren's syndrome and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin–1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist gene polymorphism in Japanese patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schönlein nephritis and IgA nephropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Association of interleukin-1 gene polymorphisms with early-onset periodontitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Imbalance production between interleukin-1beta (IL-1beta) and IL-1 receptor antagonist (IL-1Ra) in bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Polymorphisms of the IL-1 gene complex in coal miners with silicosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1beta after live yellow fever vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Adenovirus-mediated over-expression of interleukin-1 receptor antagonist reduces susceptibility to excitotoxic brain injury in perinatal rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Attenuation of temporary focal cerebral ischemic injury in the mouse following transfection with interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Expression of intercellular adhesion molecule 1 (ICAM-1) is reduced in permanent focal cerebral ischemic mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

Cytokine gene therapy for myocarditis by in vivo electroporation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900020-5

7 January 2021

10.1016/S1359-6101(02)00020-5

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_alsmyca6wfbq5ewadruopz3die

686243

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/alsmyca6wfbq5ewadruopz3die

24 November 2022

mapped directly with Wikidata item

686243

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference